Department of Molecular Biology, Princeton University, Princeton, New Jersey08544, United States.
Department of Chemistry, Princeton University, Princeton, New Jersey08544, United States.
J Am Chem Soc. 2022 Sep 14;144(36):16604-16611. doi: 10.1021/jacs.2c06806. Epub 2022 Sep 1.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infectious agent of the COVID-19 pandemic, remains a global medical problem. Angiotensin-converting enzyme 2 () was identified as the primary viral entry receptor, and transmembrane serine protease 2 primes the spike protein for membrane fusion. However, expression is generally low and variable across tissues, suggesting that auxiliary receptors facilitate viral entry. Identifying these factors is critical for understanding SARS-Cov-2 pathophysiology and developing new countermeasures. However, profiling host-virus interactomes involves extensive genetic screening or complex computational predictions. Here, we leverage the photocatalytic proximity labeling platform μMap to rapidly profile the spike interactome in human cells and identify eight novel candidate receptors. We systemically validate their functionality in SARS-CoV-2 pseudoviral uptake assays with both Wuhan and Delta spike variants and show that dual expression of with either neuropilin-2, ephrin receptor A7, solute carrier family 6 member 15, or myelin and lymphocyte protein 2 significantly enhances viral uptake. Collectively, our data show that SARS-CoV-2 synergistically engages several host factors for cell entry and establishes μMap as a powerful tool for rapidly interrogating host-virus interactomes.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是 COVID-19 大流行的病原体,仍然是一个全球性的医学问题。血管紧张素转换酶 2(ACE2)被鉴定为主要的病毒进入受体,跨膜丝氨酸蛋白酶 2 为刺突蛋白的膜融合做准备。然而,在不同组织中 的表达通常较低且可变,这表明辅助受体有助于病毒进入。确定这些因素对于了解 SARS-Cov-2 的病理生理学和开发新的对策至关重要。然而,宿主-病毒互作组的分析涉及广泛的遗传筛选或复杂的计算预测。在这里,我们利用光催化邻近标记平台 μMap 快速分析人类细胞中的刺突互作组,并鉴定出八个新的候选受体。我们系统地验证了它们在 SARS-CoV-2 假病毒摄取实验中的功能,包括武汉和 Delta 刺突变异株,并表明 与神经纤毛蛋白-2、表皮生长因子受体 A7、溶质载体家族 6 成员 15 或髓鞘和淋巴细胞蛋白 2 的双重表达显著增强了病毒的摄取。总的来说,我们的数据表明,SARS-CoV-2 协同结合几种宿主因子进入细胞,并确立 μMap 作为快速研究宿主-病毒互作组的有力工具。